← Leaderboards
Bellur S Prabhakar
University Of Illinois At Chicago
$8,432,775
Attributed
$8,432,775
Total exposure
12
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.2M · FY2005–24$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$8,432,775 · 10
VA$0 · 2
By mechanism
R01$5,553,099 · 4
U01$1,042,363 · 1
R21$931,220 · 2
R41$453,344 · 2
S10$452,749 · 1
I01$0 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Illinois At Chicago
Same institution · by research overlap
- Matthew Nicholas Meriggioli$899,980
- Aaron C Hinken$790,656
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMediatingBasePreventSignal TransductionCellsApoptosisEffective TherapyIn VitroCessation Of LifeResistanceTumorProteinsCancer CellApoptoticMutationKnock-DownRelative (Related Person)Signal PathwayAutoimmune DiseasesMalignant NeoplasmsT-LymphocytePharmaceutical PreparationsMouse Model
Grant awards (37)
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer$0
I01 · FY2024 · VA · contact PI
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer$0
I01 · FY2023 · VA · contact PI
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer$0
I01 · FY2022 · VA · contact PI
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer$0
I01 · FY2021 · VA · contact PI
Co-targeting MADD and Wnt/β-catenin signaling in Anaplastic Thyroid Cancer$0
I01 · FY2020 · VA · contact PI
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer$0
I01 · FY2019 · VA · contact PI
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer$0
I01 · FY2018 · VA · contact PI
G-BMDC-induced Treg mediated suppression of Type 1 Diabetes in NOD mice$399,750
R01 · FY2017 · AI · contact PI
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer$0
I01 · FY2017 · VA · contact PI
G-BMDC-induced Treg mediated suppression of Type 1 Diabetes in NOD mice$399,750
R01 · FY2016 · AI · contact PI
A chimeric protein for the selective expansion of regulatory T cells$260,665
R41 · FY2016 · AI · contact PI
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer$0
I01 · FY2016 · VA · contact PI
G-BMDC-induced Treg mediated suppression of Type 1 Diabetes in NOD mice$399,500
R01 · FY2015 · AI · contact PI
Overcoming Therapeutic Resistance in Anaplastic Thyroid Cancer$0
I01 · FY2015 · VA · contact PI
G-BMDC-induced Treg mediated suppression of Type 1 Diabetes in NOD mice$399,500
R01 · FY2014 · AI · contact PI
Use of Bispecific Antibody for Treating Non-obese Diabetes$192,679
R41 · FY2011 · AI · contact PI
Characterization of therapeutic human monoclonal antibodies against SARS$473,173
U01 · FY2010 · AI · contact PI
Therapeutic treatment of EAT by inducing dendritic cell$361,201
R01 · FY2010 · AI · contact PI
Characterization of therapeutic human monoclonal antibodies against SARS$569,190
U01 · FY2009 · AI · contact PI
Therapeutic treatment of EAT by inducing dendritic cell$364,849
R01 · FY2009 · AI · contact PI
Novel human gene-IG20-potential role in cancer therapy$261,235
R01 · FY2009 · CA · contact PI
Therapeutic treatment of EAT by inducing dendritic cell$364,849
R01 · FY2008 · AI · contact PI
Novel human gene-IG20-potential role in cancer therapy$261,235
R01 · FY2008 · CA · contact PI
Therapeutic treatment of EAT by inducing dendritic cell$371,915
R01 · FY2007 · AI · contact PI
Novel human gene-IG20-potential role in cancer therapy$261,235
R01 · FY2007 · CA · contact PI
Therapeutic treatment of EAT by inducing dendritic cell$383,023
R01 · FY2006 · AI · contact PI
Novel human gene-IG20-potential role in cancer therapy$269,038
R01 · FY2006 · CA · contact PI
Novel human gene-IG20-potential role in cancer therapy$275,513
R01 · FY2005 · CA
Induction of tolerance to islet cell transplants$310,310
R21 · FY2004 · AI
Induction of tolerance to islet cell transplants$310,310
R21 · FY2003 · AI
EXPERIMENTAL AUTOIMMUNE GRAVES'DISEASE$203,861
R01 · FY2003 · DK
Becton Dickinson Flow Cytometry System$452,749
S10 · FY2002 · RR
EXPERIMENTAL AUTOIMMUNE GRAVES'DISEASE$197,925
R01 · FY2002 · DK
EXPERIMENTAL AUTOIMMUNE GRAVES'DISEASE$192,160
R01 · FY2001 · DK
MOLECULAR MIMICRY BETWEEN Y ENTEROCOLITICS AND TSHR$155,300
R21 · FY2001 · DK
EXPERIMENTAL AUTOIMMUNE GRAVES'DISEASE$186,560
R01 · FY2000 · DK
MOLECULAR MIMICRY BETWEEN Y ENTEROCOLITICS AND TSHR$155,300
R21 · FY2000 · DK